Veterans with both opioid and cannabis use disorders had fewer opioid prescriptions but more psychiatric hospitalizations
Among veterans with drug use disorders, those with co-occurring opioid and cannabis use disorders received fewer opioid prescriptions than those with opioid use disorder alone, but had higher rates of psychiatric admission and homelessness.
Quick Facts
What This Study Found
Veterans with co-occurring OUD and CUD received fewer opioid prescriptions (mean 3.79 vs 4.8) compared to the OUD-only group, but had a higher likelihood of inpatient psychiatric admission (RR = 1.95) and homelessness (RR = 1.52).
Key Numbers
234,181 veterans studied (94% male). Co-occurring OUD+CUD group: 8.6% of sample. Mean opioid prescriptions: 3.79 (OUD+CUD) vs 4.8 (OUD only). Psychiatric admission risk ratio: 1.95. Homelessness risk ratio: 1.52. No significant difference in ED visits.
How They Did This
Retrospective analysis of 234,181 veterans with drug use disorder diagnoses from the National Veterans Health Administration, comparing outcomes across four groups: co-occurring OUD+CUD, OUD only, CUD only, and other drug use disorders using logistic and linear regression models.
Why This Research Matters
The idea that cannabis might substitute for opioids has gained attention, but this study shows the relationship is complicated. While cannabis co-use was associated with fewer opioid prescriptions, it didn't translate to better overall outcomes.
The Bigger Picture
The opioid-cannabis substitution hypothesis is appealing but oversimplified. These findings suggest that while cannabis co-use correlates with lower opioid prescribing, the people using both substances face compounding challenges that outweigh any prescribing reduction.
What This Study Doesn't Tell Us
Retrospective design cannot establish causation. The veteran population is predominantly male, limiting generalizability. Cannabis use disorder is clinically different from controlled medical cannabis use. Self-reported SC use relied on honesty.
Questions This Raises
- ?Would supervised medical cannabis programs for OUD patients show different outcomes than the uncontrolled co-use patterns seen here?
- ?Are the worse psychiatric outcomes driven by the combination of substances or by underlying severity?
Trust & Context
- Key Stat:
- 234,181 veterans: OUD+CUD group had 1.95x higher psychiatric admission risk
- Evidence Grade:
- Moderate: large national dataset with regression modeling, but retrospective and observational.
- Study Age:
- Published in 2019, using FY2012 data.
- Original Title:
- Adverse Consequences of Co-Occurring Opioid Use Disorder and Cannabis Use Disorder Compared to Opioid Use Disorder Only.
- Published In:
- The American journal of drug and alcohol abuse, 45(5), 527-537 (2019)
- Authors:
- De Aquino, Joao P(12), Sofuoglu, Mehmet(8), Stefanovics, Elina, Rosenheck, Robert
- Database ID:
- RTHC-02001
Evidence Hierarchy
Looks back at existing records to find patterns.
What do these levels mean? →Frequently Asked Questions
Does cannabis help people use fewer opioids?
In this study, veterans with both opioid and cannabis use disorders received fewer opioid prescriptions. However, they also had worse outcomes in other areas like psychiatric hospitalization, so the picture is more complex than simple substitution.
Why were psychiatric admissions higher in the dual-use group?
The study couldn't determine causation. It may reflect greater overall substance use severity, compounding effects of multiple substances, or other unmeasured factors common to people with multiple use disorders.
Read More on RethinkTHC
- 420-sober-survival-guide
- CBT-cannabis-recovery
- cannabis-dependence-physical-psychological-addiction-science
- cannabis-perception-vs-evidence-gap
- cannabis-relapse-cycle-pattern
- cannabis-use-disorder-test
- cold-turkey-vs-taper-quit-weed
- cross-addiction-quit-weed-start-drinking
- dating-sober-after-quitting-weed
- exercise-quitting-weed-anxiety-brain
- grieving-quitting-weed-loss
- help-someone-quit-weed
- how-to-quit-weed
- is-weed-addictive
- is-weed-addictive-science
- journaling-weed-withdrawal
- marijuana-anonymous-SMART-recovery-compare
- meditation-mindfulness-weed-withdrawal
- partner-still-smokes-weed
- partner-still-smokes-weed-quitting
- pink-cloud-sobriety-cannabis
- quit-weed-cold-turkey
- quit-weed-or-cut-back-which-is-better
- quit-weed-regret-went-back
- quitting-weed-20s
- quitting-weed-30s
- quitting-weed-after-years
- quitting-weed-and-alcohol
- quitting-weed-during-crisis-divorce-job-loss
- quitting-weed-exercise
- quitting-weed-grief-loss-coping
- quitting-weed-legal-state
- quitting-weed-success-stories
- quitting-weed-triggers-environment
- rehab-for-weed-addiction-necessary
- relapsed-smoking-weed-what-to-do
- relapsed-weed
- should-i-quit-weed
- signs-of-cannabis-use-disorder
- sober-music-festival-concert-without-weed
- supplements-weed-withdrawal
- telling-friends-quitting-weed
- weed-relapse-prevention-plan
- weed-relapse-why-it-happens
- weed-ritual-replacement
- weed-ruined-relationships
- weed-social-media-triggers-quit
- weed-vape-pen-addiction
Cite This Study
https://rethinkthc.com/research/RTHC-02001APA
De Aquino, Joao P; Sofuoglu, Mehmet; Stefanovics, Elina; Rosenheck, Robert. (2019). Adverse Consequences of Co-Occurring Opioid Use Disorder and Cannabis Use Disorder Compared to Opioid Use Disorder Only.. The American journal of drug and alcohol abuse, 45(5), 527-537. https://doi.org/10.1080/00952990.2019.1607363
MLA
De Aquino, Joao P, et al. "Adverse Consequences of Co-Occurring Opioid Use Disorder and Cannabis Use Disorder Compared to Opioid Use Disorder Only.." The American journal of drug and alcohol abuse, 2019. https://doi.org/10.1080/00952990.2019.1607363
RethinkTHC
RethinkTHC Research Database. "Adverse Consequences of Co-Occurring Opioid Use Disorder and..." RTHC-02001. Retrieved from https://rethinkthc.com/research/de-2019-adverse-consequences-of-cooccurring
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.